The Role of Toxicological Interactions in Chemical Carcinogenesis

Abstract

Toxicological interactions may occur not only when exposure to two or more chemicals is simultaneous, but also when exposures are separated in time. Often the sequence of exposure determines the nature of the toxicological response. This is illustrated with the two hindered phenolic antioxidants, butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA). Evidence available suggests that in certain tissues exposure to BHT first and then to a carcinogen is without significant consequences, whereas exposure to BHT after a carcinogen may enhance tumor formation. On the other hand, exposure to BHA before carcinogen administration often has a protective effect, whereas exposure to BHA after a carcinogen sometimes protects and sometimes is without any influence. Mechanisms underlying these interactions may be induction of mixed function oxidases, production of cell hyperplasia or other, as yet ill-defined, events such as modification of biological reactivity.

References

1. National Academy of Sciences (1980). Principles of Toxicological Interactions Associated with Multiple Chemical Exposures. pp. 1/4 to 1/5. National Academy Press, Washington, D.C.

2. Witschi HP (1982): Altered tissue reactivity and interaction between chemicals. In: Assessment of Multichemical Contamination. National Academy Press. Washington, D.C., pp. 263–288.

3. Shimkin MD and Stoner GD (1975). Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 21:1–58.

4. Hirai KI , Witschi HP , and Côté MG (1977). Electron microscopy of butylated hydroxytoluene induced lung damage in mice. Exp. Mol. Pathol. 27:295–308.

5. Witschi HP and Morse CC (1983). Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: Dose-time relationships and cell kinetics. J. Natl. Cancer Inst. 71:859–866.

6. Witschi HP , Hakkinen PJ and Kehrer JP (1981). Modification of lung tumor development in A/J mice. Toxicology 21:37–45.

7. Witschi HP (1981). Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology 21:95–105.

8. Witschi HP and Doherty DG (1984): Butylated hydroxyanisole and lung tumor development in A/J mice. Fundamental Appl. Toxicol. (in press).

9. Wattenberg LW (1978). Inhibition of chemical carcinogenesis. J. Natl. Cancer Inst. 60:11–18, 1978.

10.

10. McCormick DL and Moon RC (1983). Inhibition of rat mammary carcinogenesis by pre- and postcarcinogen administration of antioxidants. Proc. Amer. Assoc. Cancer Res. 24:97.

11.

11. Ito N , Fukushima S , Hagiwara A , Shibata M and Ogiso T (1983). Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst. 70:343–352.

12.

12. Babich H (1982). Butylated hydroxytoluene (BHT): A review. Environ. Res. 29:1–29.

13.

13. Peraino C , Fry RJM , Staffeldt E and Christopher P (1977). Enhancing effects of phenobarbital and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet. Toxicol. 15:93–96.

14.

14. Olsen P , Bille N and Meyer O (1983). Hepatocellular neoplasms in rats induced by butylated hydroxytoluene (BHT). Acta Pharmacol. Toxicol. 53:433–434.

15.

15. Williams GM , Maeura Y and Weisburger JH (1983). Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluormylacetamide by butylated hydroxytoluene. Cancer Lett 19:55–60.